DMeOB

CAS No. 40252-74-2

DMeOB( —— )

Catalog No. M33845 CAS No. 40252-74-2

DMeOB (3,3'-Dimethoxybenzaldazine) is a negative regulator with mGluR5 agonist activity and can be used to study neurological diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 46 In Stock
5MG 61 In Stock
10MG 101 In Stock
25MG 196 In Stock
50MG 302 In Stock
100MG 446 In Stock
500MG 963 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DMeOB
  • Note
    Research use only, not for human use.
  • Brief Description
    DMeOB (3,3'-Dimethoxybenzaldazine) is a negative regulator with mGluR5 agonist activity and can be used to study neurological diseases.
  • Description
    DMeOB is an agonist ofmGluR5 receptor with an IC50 of 3 μM. DMeOB has a negative modulatory effect.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Neuroscience
  • Target
    GluR
  • Recptor
    GluR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    40252-74-2
  • Formula Weight
    268.31
  • Molecular Formula
    C16H16N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(N=CC=1C=CC=C(OC)C1)=CC=2C=CC=C(OC)C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. O'Brien JA, et al. A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5. Mol Pharmacol. 2003 Sep;64(3):731-40.?
molnova catalog
related products
  • CPPHA

    CPPHA, a positive allosteric modulator of glutamate receptors mGluR5 and mGluR1, is commonly used in development for central nervous system diseases.

  • DNQX

    DNQX is a competitive non-NMDA glutamate receptor antagonist (IC50s = 0.5 and 0.1 μM for AMPA and kainate receptors respectively).

  • (S)-4CPG

    (S)-4CPG ((S)-4-Carboxyphenylglycine) is a competitive mGlu1 receptor antagonist that attenuates nociceptive hypersensitivity and nociceptive abnormalities associated with sciatic nerve constriction injuries in rats, and may be used in the study of neurological disorders.